Restoring HDAC2 expression and activity in COPD cells could prevent Nrf2 down-regulation by increased Nrf2 deacetylation resulting in the restoration of normal anti-oxidant defences. This evidence concerns the gene NFE2L2 and chronic obstructive pulmonary disease.